SCHEMBL4199680

SCHEMBL4199680

CC(CC1CCNCC1)NCc1ccccc1NC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 5/20 0.41
CHRM1 P11229 4/20 0.41
CHRM2 P08172 3/20 0.41
CXCR2 P25025 2/20 0.39
KDM4E B2RXH2 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
KMT2A Q03164 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
KDM1A O60341 1/20 0.37
RCOR1 Q9UKL0 1/20 0.37
CCR3 P51677 1/20 0.36
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
HTR4 Q13639 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4189874 0.92 KDM4E (0.43) KDM4EL3MBTL1ALDH1A1POLBKMT2A
SCHEMBL4192548 0.88 KMT2A (0.47) KDM4EL3MBTL1ALDH1A1POLBKMT2A
SCHEMBL4201586 0.84 KMT2A (0.43) KDM4EL3MBTL1ALDH1A1POLBKMT2A
SCHEMBL4707714 0.83 MAPT (0.54) KDM4EL3MBTL1ALDH1A1POLBKMT2A
SCHEMBL4197522 0.80 THRB (0.37) CHRM1CXCR2POLBKMT2AKDM1A
SCHEMBL4199612 0.80 POLB (0.41) KDM4EALDH1A1POLBKMT2A
SCHEMBL4195010 0.80 CXCR2 (0.36) CXCR2KMT2AKDM1ARCOR1CCR3
SCHEMBL4196799 0.77 CCR3 (0.50) KDM4EALDH1A1KMT2ACCR3
SCHEMBL4197445 0.77 KMT2A (0.48) L3MBTL1ALDH1A1POLBKMT2ACCR3
SCHEMBL4196629 0.77 KMT2A (0.48) L3MBTL1ALDH1A1POLBKMT2ACCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 CHRM3 3314/4885CHRM1 3424/4885CHRM2 4365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.